# Red-team Round 2 — synthesis (attack on the reliability-first reframe)

Round 1 moved the load-bearing novelty to RELIABILITY ("the vasopressor requirement is a stable patient
TRAIT"). Round 2 attacked that keystone with four adversaries (reliability construct skeptic,
between-encounter test-retest, clinical so-what, fully-adjusted robustness). Per-reviewer docs:
RED_TEAM_ROUND2_{RELIABILITY,RETEST,SOWHAT,ADJUST}.md.

## The decisive result: the "stable patient trait" claim DID NOT SURVIVE
The settling test — does a patient's vasopressor requirement in one ICU admission predict their
requirement in a *separate* admission? — was run on 1,712 multi-stay MIMIC subjects (median inter-stay
gap 54.8 d):

| Construct | r | ICC(2,1) | What it is |
|---|---|---|---|
| Within-stay split-half (odd/even segments) | 0.78–0.95 | 0.77 | **infusion autocorrelation** (a slowly-titrated drip; not a phenotype) |
| Within-stay early→late half | 0.62 | — | genuine within-encounter early-warning predictability |
| Within-stay, gap ≥24 h | 0.30 | — | ≈ the cross-encounter number |
| **Cross-encounter (separate ICU stays)** | **0.087** | **0.074** | **the honest patient-trait reliability** |
| Cross-encounter, gap ≥30 d | 0.056 | 0.049 | — |
| INSPIRE cross-procedure (different operations) | 0.317 | — | between-encounter, surgical |

By the construct skeptic's pre-stated rule (<0.20 → drop "trait" language), the **cross-encounter ICC
0.07 retracts the "stable patient trait" framing.** The requirement is an **acute, encounter-level
severity signal** (age correlates −0.03 with it — not a fixed patient characteristic), not a phenotype
that travels with the patient. The headline 0.95 is within-drip autocorrelation that nobody disputes and
that VIS already implies.

## What this does to the paper
The Round-1 reframe is itself **retracted**: reliability-as-trait cannot be the novel contribution
because the trait reliability is ~0.07. We do NOT get to claim a stable phenotype.

## What genuinely survives Round 2 (honest inventory)
1. **Within-encounter early→late predictability (0.62):** the early requirement predicts the later
   requirement *within the same encounter* — a real early-warning property (NOT a cross-encounter trait).
2. **Control-theory framing (VitalDB):** intraop MAP is feedback-regulated (MAP CV 0.09 ≪ dose CV 0.44);
   the dose/requirement carries insult information the regulated pressure conceals. Novel vs VIS — but
   shown only intraoperatively.
3. **Fully-adjusted prospective dose-response (the landmark):** first-24 h NEE → post-24 h death,
   OR **1.74 [1.57, 1.91]** (IPCW 1.64), **delta-AUC 0.024 [0.016, 0.035]** over age+lactate+SOFA-labs+
   comorbidity — clinically meaningful beyond severity, reverse-causation defeated by design.
   BUT: (a) this is the **known VIS / vasopressor-load → mortality** territory (Roberts 2020, Saugel
   2025, VIS meta-analysis) — not novel as a headline; (b) E-value 2.1–2.3 is *exceeded* by two
   known-missing confounders (SOFA GCS, PaO₂/FiO₂); (c) 82% complete-case loss → multiple imputation
   needed as primary; (d) duration matters (peak-only OR 1.42).
4. **Honest negatives:** concordance null (no decision-benefit); MAP-target HTE null; requirement is
   not a trait.

## The reckoning (against the Anesthesiology-tier-or-above goal)
After two adversarial rounds, **no clean Anesthesiology-tier POSITIVE finding survives as framed:**
- the novel part (trait) is **dead** (cross-encounter ICC 0.07);
- the strong part (dose → mortality, delta-AUC 0.024) is **real but known** (VIS literature) — a
  rigorous confirmation/extension, not a top-tier novelty;
- the genuinely novel framing (control theory) is shown **only intraoperatively**, where the outcome
  signal is weak (elective-surgery low mortality / INSPIRE intraop NEE OR ~1.11).

Honest tiers for what survives:
- **A rigorous dose→outcome + control-theory + landmark-methodology paper → BJA / Anesthesia & Analgesia**
  (clean, well-controlled, but VIS-adjacent).
- **A cautionary "the vasopressor requirement is not a patient trait — within-encounter reliability is
  autocorrelation" methods paper → A&A / a methods venue** (rigorous, modest novelty).
- An **Anesthesiology-tier positive finding would require a new angle or new data** (e.g., the intraop
  control-theory mechanism validated against a hard intraop outcome in a waveform cohort; or a
  genuinely novel exposure not in the VIS canon).

This is a hostile-review SUCCESS: two rounds converted an overstated "reliable mortality-grading patient
trait" into an honest, correctly-scoped account before submission. The next decision (which surviving
angle to drive to 100%, accept a lower tier, pivot to a new idea, or report the negative) is a strategy
call recorded for the user in the session.

Cross-ref: RED_TEAM_ROUND2_{RELIABILITY,RETEST,SOWHAT,ADJUST}.md, RED_TEAM_ROUND1_SYNTHESIS.md,
IDEAS_LEDGER.md, FINDING4_LANDMARK.md.
